期刊文献+

氧化型低密度脂蛋白对正常人外周血单核细胞凝集素样氧化低密度脂蛋白受体-1及尿激酶型纤溶酶原激活剂受体蛋白表达的影响 被引量:1

Effect of Oxidative LDL on Protein Expressions of Lectin Like Oxidized LDL Receptor-1 and Urokinase Type Plasminogen Activator Receptor in Normal Human Peripheral Blood Mononuclear Cells
下载PDF
导出
摘要 目的:探讨不同时间点不同浓度氧化型低密度脂蛋白(oxLDL)对正常人外周血单核细胞凝集素样氧化低密度脂蛋白受体-1(LOX-1)、尿激酶型纤溶酶原激活剂受体(uPAR)蛋白的表达情况的影响。方法:选取正常人外周血经Ficoll密度梯度离心法分离人外周血单个核细胞(PBMC),用含20%自体血清的RPMI1640完全培养基培养,收取其帖壁的单核细胞,以免疫印迹杂交法(Western Blot)方法检测不同浓度oxLDL对正常人单核细胞干预24h,72h的uPAR、LOX-1的蛋白表达。结果:oxLDL干预正常人单核细胞24小时后,随着其浓度的增加uPAR及LOX-1蛋白表达上调,在50μg/ml时达峰,而高浓度组(100μg/ml)对两者的蛋白表达起着抑制作用。oxLDL刺激正常人单核细胞72小时后,低浓度(10μg/ml)不能有效地增加uPAR的表达,较高浓度(50μg/ml、100μg/ml)能够较有效地增加uPAR的表达。oxLDL刺激正常人单核细胞72小时后,LOX-1的表达随着浓度的增加而上调,但浓度≥50μg/ml时,其表达有所下降。结论:本研究中oxLDL不同作用时间对uPAR及LOX-1的影响不同,提示了oxLDL致炎症过程的复杂性。 Objective: To investigate the effect of oxidative LDL (oxLDL) on protein expressions of lectin like oxidized low density lipoprotein receptor-1 (LOX-1) and urokinase type plasminogen activator receptor (uPAR) in normal human peripheral blood mononuclear cells (PBMC). Methods: The normal human PBMC was isolated by Ficoll-paque density gradient centrifugation and cultured with RPMI 1640 medium with 20% antologous serum. Western blot was conducted to detect the effect of oxLDL at different concentrations and time periods on protein expressions of LOX-1 and uPAR in normal human PBMC. Results: For 24-hour oxLDL treatment, the protein expressions of uPAR and LOX-1 were increased with the elevated oxLDL concentrations, oxLDL 50 ~tg/ml was the peak, while the expressions were inhibited by oxLDL 100 μg/ml. With 72- hour oxLDL treatment, the low concentration of oxLDL 10 μg/ml could not increase uPAR protein expression, while oxLDL 50 μg/ml and 100 μg/ml could effectively increase uPAR protein expression; the LOX-1 expression was increased according to the elevated oxLDL concentrations, while the expression decreased at oxLDL ≥ 50 μg/ml. Conclusion: Our work indicated that different concentrations and time periods of oxLDL treatment may affect the protein expressions ofuPAR and LOX-1 at different degrees which suggested that oxLDL-induced inflammatory process was complicated.
出处 《中国循环杂志》 CSCD 北大核心 2014年第4期288-291,共4页 Chinese Circulation Journal
关键词 氧化低密度脂蛋白 尿激酶型纤溶酶原激活剂 凝集素样氧化低密度脂蛋白受体-1 Oxidative LDL Lectin like oxidized low density lipoprotein receptor-I Urokinase type plasminogenactivator receptor
  • 相关文献

参考文献13

  • 1Kiyan Y, Tkachuk S, Hilfiker-Kleiner D, et al, oxLDL induces inflammatory responses in vascular smooth muscle ceils via urokinase receptor association with CD36 and TLR4. J Mol Cell Cardiol, 2013, 66c: 72-82.
  • 2Moriwaki H, Kume N, Sawamura T, et al. Ligand specificity of LOX- 1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol, 1998, 18:1541-1547.
  • 3Lusis A J, Atherosclerosis. Nature, 2000, 407:233-241.
  • 4May AE, Neumann FJ, Preissner KT. The relevance of blood cell vessel wall interactions for vascular thrombotic disease. Thromb Haemost, 1999, 82:962-970.
  • 5Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation, 2013, 127: 143-152.
  • 6Ross R. Atherosclerosis is an inflammatory disease. N Engl J Med , 1999,340 : 115- 126.
  • 7Edsfeldt A, Nitulescu M, Grufman H, et al. Soluble urokinase plasminugen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque. Stroke, 2012, 43: 3305- 3312.
  • 8Dunn S, Vohra RS, Murphy JE, et al. The lectin-like oxidized low- density- lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J. 2008. 409: 349-355.
  • 9马胜超,孙炜炜,巩慧慧,马长剑,王菊,田珏,姜怡邓.凝集素样氧化低密度脂蛋白受体-1甲基化在同型半胱氨酸作用下对人内皮细胞存活的影响[J].中国循环杂志,2013,28(2):148-151. 被引量:5
  • 10Mehta JL, Li DY. Identification and autoregulation of receptor for oxLDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun, 1998, 248:511-514.

二级参考文献37

  • 1陈文强,张运,张梅,季晓平,丁士芳,陈玉国,李贵双,李大庆,苏海军.心绞痛患者血清炎性因子和斑块超声显像特征的相关性研究[J].中华医学杂志,2004,84(13):1062-1065. 被引量:38
  • 2郑平,刘学文,祁哲,丛祥凤.别嘌呤醇对同型半胱氨酸和低密度脂蛋白协同损伤血管内皮细胞的保护作用[J].中国循环杂志,2005,20(3):172-175. 被引量:3
  • 3胡允兆,董吁钢,翟玉锋,卢剑华,吴焱贤,周艺,何宗云.辛伐他汀对同型半胱氨酸诱导的人脐静脉内皮细胞的毒性和炎症反应的影响[J].中华医学杂志,2006,86(32):2297-2300. 被引量:3
  • 4Bonetti C, Dimmeler S, Hamm CW, et al. Statin effects beyond cholesterol lowering-are they clinical relevant? Eur Heart J, 2003, 24: 225 -248.
  • 5Sawaynama Y, Shimizu C, Maeda N, et al. Effects of Probucol and common carotid atherosclerosis in patients with asymptomatic hypercholesterol emia. Fukuoka Antherosc-lerosis Trial (FAST). J Am Coll Cardiol. 2002. 39(4) :610-616.
  • 6Franceschini G, Chiesa G, Sirtori CR. Probucol increases cholesterol ester transfer protein activity in hypercholesteraemia patients. Eur J Clin Invest, 1991,21 (4) : 384-388.
  • 7Jean C, Ranch U, Fuster U, et al. Effects of probucol on vascular remodeling after Percutaneous Coronary Interventions. Circulation,2003, 2(4) :552-558.
  • 8Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient. A call for new definition and risk assessment strategies : part Ⅰ and part Ⅱ. Circulation, 2003,108 : 1664-1778.
  • 9Ross R, Badimon JJ, Zaman A, et al. Atherosclerosis-an inflammatory disease. N Eng J Med, 1999, 340: 115-126.
  • 10Koerig W, Cannon CP, Fuster U, et al. Inflammation and coronary heart disease: an overview. Cardio Rev,2001,9:31-35.

共引文献6

同被引文献10

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部